ESMO Breast 2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

ESMO Breast 2025
May 22, 2025, 08:56 | Blog
The Jules Bordet Institute was widely represented at ESMO Breast 2025, the major European congress on breast cancer
Institut Jules Bordet shared a post on LinkedIn: "[ESMO BREAST 2025] The Jules Bordet Institute…
May 18, 2025, 15:25 | Insight
Matteo Lambertini: Honored for the Opportunity to Contribute to ESMO Breast 2025
Matteo Lambertini, Associate Professor at the University of Genova, shared a post on LinkedIn: "What…
May 18, 2025, 13:31 | Blog
Sarah Scagliarini: Working Together to Improve PROs in Cancer Trials and RWE
Sarah Scagliarini, Medical Oncologist at AORN Cardarelli in Naples, shared a post on X by…
May 18, 2025, 11:58 | Blog
Zacharoula Sidiropoulou Calls for Global Investment in Access to Cancer Surgery in LMICs
Zacharoula Sidiropoulou, Senior Consultant Breast Surgical Oncologist at Hospital São Francisco Xavier, shared a post…
May 18, 2025, 11:12 | Blog
Pablo Mando: Honored and Privileged to Have Been Part of the Faculty of BCY at ESMO Breast 2025
Pablo Mando, Clinical Oncologist at CEMIC, Buenos Aires, Argentina, shared a post on X: "It’s…
May 18, 2025, 07:09 | Societies
Do Clinicians and Patients See the Same Picture? - Contrasting CROs vs PROs in Recent ESMO Breast 2025 Studies
ESMO shared a post on LinkedIn: "Do clinicians and patients see the same picture? Studies…
May 17, 2025, 15:28 | Blog
Yakup Ergün: Great Debate on Continuing CDK4/6 After Progression
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: "ESMO Breast 2025 Great…
May 17, 2025, 15:23 | Oncolibrary
SGNTUC-019 Trial Final Results: Tucatinib + Trastuzumab Shows Durable Benefit in HER2-Mutant MBC at ESMO 2025
The final analysis of the SGNTUC-019 trial Phase II basket trial provides compelling evidence that…
May 17, 2025, 13:47 | Blog
Rasha Aboelhassan: From screening to early diagnosis and treatments at ESMO Breast 2025
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared on LinkedIn: "From screening to early…
May 17, 2025, 10:33 | Blog
HYPART Trial: Testing 1-Week vs. 2-Week Radiotherapy for High-Risk Breast Cancer at ESMO Breast 2025
At the ESMO Breast Cancer Congress 2025 Dr. Budhi S. Yadav  (Chandigarh, India) presented finding from…
May 17, 2025, 08:55 | Blog
Seyed Alireza Javadinia: MPA-Guided Chemotherapy Strategy in ER+/HER2- BC Presented at ESMO Breast 2025
Seyed Alireza Javadinia, Vice President for Research and Technology, Assistant Professor and Radiation Oncologist at…
May 17, 2025, 08:47 | Blog
Amol Akhade: New Hope in HER2+ and HER2-Low mBC?
Amol Akhade, Senior Consultant Medical Oncologist and Hemato-Oncologist at Suyog Cancer Clinics and Reliance Hospitals,…
May 17, 2025, 07:23 | Blog
Seyed Alireza Javadinia: Findings from ADAPTcycle Trial at ESMO Breast 2025
Seyed Alireza Javadinia, Vice President for Research and Technology, Assistant Professor and Radiation Oncologist at…
May 16, 2025, 18:00 | Oncolibrary
EL1SSAR Trial: ESMO 2025 Newest Data Support Atezolizumab + Nab-Paclitaxel in PD-L1+ TNBC
At the ESMO Breast Cancer Congress 2025, Dr. Suzette Delaloge presented the primary results from…
May 16, 2025, 17:42 | Blog
APHINITY Trial Update Shows OS Benefit with Pertuzumab in HER2+ Breast Cancer - ESMO
European Society for Medical Oncology (ESMO) shared a post on LinkedIn: "As presented as a…
May 16, 2025, 17:04 | Blog
Elia Seguí: Happy to have presented today at ESMO Breast 2025 our work on TLS in breast cancer
Elia Seguí, Research Fellow - Breast Oncology at Dana-Farber Cancer Institute, shared on LinkedIn: "Super…
May 16, 2025, 12:17 | Science
ROSALINE Trial Reports 49% Response in Lobular Breast Cancer at ESMO 2025
Dr. Soraia Lobo Martins (Brussels, Belgium) presented results from the Phase II ROSALINE trial at…
May 16, 2025, 08:51 | Insight
Ahmed Alanazi: Subgroup Insights from EMBER3 Study - Is Combo Better Than SERDs Alone?
Ahmed Alanazi, Department Program Director at King Fahad Medical City, shared a post on X: "EMBER3 updates…
May 16, 2025, 05:13 | Blog
Paolo Tarantino: Davide Massa Presented Interesting Retrospective Analysis at ESMO Breast 2025
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Interesting retrospective…
May 15, 2025, 18:17 | Blog
Tanja Spanic: Fantastic Sessions at the First day of ESMO Breast 2025
Tanja Spanic, Secretary General of Europa Donna Slovenia, shared a post on LinkedIn: "First day…
May 15, 2025, 13:36 | Oncolibrary
EMBER-3 Trial Updates from ESMO Breast 2025: Imlunestrant Plus Abemaciclib Improves PFS in CDK4/6i-Pretreated ER+/HER2- Breast Cancer
Presented by Dr. Cristina Saura Manich (Barcelona, Spain) at the ESMO Breast Cancer Annual Congress…
May 15, 2025, 11:17 | Insight
Highlights from ESMO Breast 2025 by Rasha Aboelhassan
The ESMO Breast Cancer Congress 2025 taking place in Munich, Germany, on May 14-17, 2025, with an…
May 15, 2025, 10:38 | Insight
Highlights from ESMO Breast 2025 by Amol Akhade
Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics, shared a post on X: "New ADC…
May 9, 2025, 09:39 | Blog
Yakup Ergün: One of the Key Upcoming Presentations at ESMO Breast 2025
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X: "ESMO Breast…
May 5, 2025, 12:17 | Blog
Paolo Tarantino: Personal Selection of 10 Key Presentations to Follow During The ESMO Breast 2025
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Only 2…
May 3, 2025, 12:22 | Blog
Paolo Tarantino: Only 2 weeks to ESMO Breast 2025
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, posted on LinkedIn: "Only 2 weeks to…
Apr 14, 2025, 12:14 | Blog
Amol Akhade: Important Sessions to Watch at ESMO Breast 2025 in Munich
Amol Akhade, Senior consultant of Medical oncology and Heamto oncology at Reliance Hospitals, shared on…
Feb 11, 2025, 07:07 | Blog
Last chance to submit your abstract for ESMO Breast 2025
ESMO - European Society for Medical Oncology posted on LinkedIn: "ESMO Breast 2025: Time is running…
All: 28 Posts: 1 - 100
Special Coverage